source
- Cellular Intelligence hires neurologist to assess Novo Nordisk's Parkinson's stem cell programCellular Intelligence, an AI‑driven biotech, announced it is evaluating Novo Nordisk's Parkinson's stem cell therapy after Novo shut down its cell therapy unit. The company engaged neurologist and…
- ARPA-H earmarks $160 million for custom gene-editing therapies, sparking debate on adequacyARPA-H announced a $160 million investment to support development of bespoke gene‑editing treatments. This follows a recent case where an infant was rescued from a lethal disease using a personaliz…